Paul J Hastings Nkarta, Inc. (NKTX) insider trading activity

Paul J Hastings is Chief Executive Officer of Nkarta, Inc.. Currently has a direct ownership of 320,069 shares of NKTX, which is worth approximately $665,743. The most recent transaction as insider was on Jun 18, 2025, when has been sold 1,790 shares (Common Stock) at a price of $1.79 per share, resulting in proceeds of $3,204. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K

0.07% 3M change

32.95% 12M change

Total Value Held $665,743

PAUL J HASTINGS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2025	SELL Open market or private sale	$3,204 $1.79 p/Share	1,790 Reduced 0.56%	320,069 Common Stock
Jan 15 2025	SELL Open market or private sale	$38,231 $2.2 p/Share	17,378 Reduced 5.15%	319,859 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	94,500 Added 21.89%	337,237 Common Stock
Jun 18 2024	SELL Open market or private sale	$9,912 $5.6 p/Share	1,770 Reduced 0.73%	240,737 Common Stock
Mar 04 2024	SELL Sale (or disposition) back to the issuer	$1,834,767 $13.33 p/Share	137,642 Reduced 36.4%	240,507 Common Stock
Mar 01 2024	SELL Sale (or disposition) back to the issuer	$160,654 $13.0 p/Share	12,358 Reduced 3.16%	378,149 Common Stock
Jan 16 2024	SELL Open market or private sale	$84,751 $8.74 p/Share	9,697 Reduced 2.42%	390,507 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	85,000 Added 17.52%	400,204 Common Stock
Jun 20 2023	SELL Open market or private sale	$8,264 $4.85 p/Share	1,704 Reduced 0.54%	313,402 Common Stock
Jan 17 2023	SELL Open market or private sale	$20,263 $5.49 p/Share	3,691 Reduced 1.17%	313,106 Common Stock
Jan 13 2023	BUY Grant, award, or other acquisition	-	64,500 Added 16.92%	316,797 Common Stock
Sep 29 2022	SELL Open market or private sale	$6,474 $13.0 p/Share	498 Reduced 0.2%	250,461 Common Stock
Sep 28 2022	SELL Open market or private sale	$304,589 $13.03 p/Share	23,376 Reduced 8.52%	250,959 Common Stock
Sep 21 2022	SELL Open market or private sale	$79,699 $13.01 p/Share	6,126 Reduced 2.18%	274,335 Common Stock
Jun 17 2022	BUY Grant, award, or other acquisition	-	19,500 Added 6.5%	280,461 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	41,900 Added 13.83%	260,961 Common Stock
Sep 29 2021	SELL Open market or private sale	$228,395 $26.87 p/Share	8,500 Reduced 3.74%	219,061 Common Stock
Jun 21 2021	SELL Open market or private sale	$226,440 $26.64 p/Share	8,500 Reduced 3.6%	227,561 Common Stock
Mar 30 2021	SELL Open market or private sale	$530,910 $31.23 p/Share	17,000 Reduced 6.72%	236,061 Common Stock

Also insider at

PCRX

Pacira BioSciences, Inc. Healthcare

Director

ENGN

enGene Holdings Inc.

PJH

Paul J Hastings

Chief Executive Officer

Tampa, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTX shares.

Notify only if

Value

Insider Trading

Get notified when an Nkarta, Inc. insider buys or sells NKTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nkarta, Inc.

Track Activities on NKTX

Account